CLINICAL_TRIALS trial_result · 2015-05-29

Clinical Trial Update: Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature [Phase 3]

Phase 3 trial completed evaluating the efficacy and safety of DA-3002 in children with idiopathic short stature, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Dong-A ST Co., Ltd. | Conditions: Idiopathic Short Stature | Phase 3 | Status: COMPLETED | Results posted: 2015-05-29